Navigation Links
Amsterdam Molecular Therapeutics Announces European Commission Delays Decision on Glybera® Marketing Authorisation and Requests Further Information From the CHMP
Date:1/29/2012

AMSTERDAM, January 30, 2012 /PRNewswire/ --

Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, was informed on Friday January 27, 2012 after business hours that the European Commission's Standing Committee of the European Parliament discussed on Monday January 22, 2012 the implementation decision not to grant marketing authorization for Glybera (alipogene tiparvovec) as recommended by the Committee for Human Medicinal Products (CHMP). After the discussion no clear position in favor or against granting a marketing authorization for Glybera was reached. Instead the Standing Committee considered it necessary to request additional information to the CHMP in the European Medicines Agency (EMA). A formal vote by the Standing Committee will be made on review of the additional information. It is currently unclear when a final decision will be reached.

Glybera is a gene therapy for patients with the genetic disorder lipoprotein lipase deficiency (LPLD). Currently no alternative treatment is available for patients deficient of LPL, who are suffering from recurrent pancreatitis.

On October 23, 2011, AMT received a non-approvable opinion from the CHMP (following a re-examination of the marketing approval dossier originally rejected in June 2011) despite a recommendation to approve Glybera by the Committee For Advanced Therapies (CAT). The CAT is an expert body implemented by the European Commission to prepare and advise the CHMP on decisions regarding advanced therapeutics, in particular gene and cell therapies.

"We are very encouraged by the outcome of the discussion by the European Parliament's Standing Committee to request further information from the CHMP. The evaluation of (ultra-) orphan drugs and advanced therapies is novel territory. The ongoing debate shows that the authorities are determined to find the best process of dealing with such innovative treatments and technologies. We will constructi
'/>"/>

SOURCE Amsterdam Molecular Therapeutics (AMT) B.V
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy
2. Amsterdam Molecular Therapeutics Glybera(R) Significantly Reduces the Risk of Pancreatitis in LPLD Patients
3. Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
4. Pharma and Food Thought Leaders Set to Converge in Amsterdam Next April 2011
5. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
6. MolecularHealth to Introduce Knowledge-Driven Solutions that Enhance Drug Safety and Enable Molecularly-Guided Treatment Decision Support
7. Molecular Imaging, Inc. Enters Relationship with Dana-Farber Cancer Institute to Expand Luciferase-reporter Cancer Cell Lines for Preclinical in vivo Imaging
8. Quest Diagnostics Launches Simplexa™ Dengue Test in Brazil, First Commercial Molecular Test Approved for Nations Public and Private Health Testing
9. Roche Diagnostics, Cedars-Sinai Medical Center Enter Strategic Alliance for Center to Operate as a Roche Molecular Center of Excellence
10. Pieris Announces Results and Successful Completion of its PRS-050 Anticalin Phase I Trial at AACR-EORTC-NCI Molecular Targets and Cancer Therapeutics Conference
11. GenturaDx to Host Poster Presentation at Association for Molecular Pathology 2011 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... Ga. , July 6, 2015  EndoChoice Holdings, ... its second quarter 2015 financial results on Thursday, August ... EndoChoice will hold a conference call on Thursday, August ... results. The dial-in numbers are (866) 807-9684 for domestic ... webcast of the conference call will be available on ...
(Date:7/6/2015)... July 6, 2015  Nitin Tandon, M.D., UTHealth ... Memorial Hermann Mischer Neuroscience Institute at ... RNS® System technology into the skull of a ... of seizures – the first time this procedure ... "Epilepsy is a neurological condition that affects ...
(Date:7/6/2015)... 6, 2015 Mauna Kea ... multidisciplinary confocal laser endomicroscopy platform, announced today it ... Ministry of Health, Labor and Welfare (MHLW) ... the AQ-Flex 19 miniprobe.   Used ... miniprobe is comprised of a fiber-optic microscope that ...
Breaking Medicine Technology:EndoChoice to Report Second Quarter 2015 Financial Results on August 6, 2015 2Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 2Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 3Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 4Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3
... REDWOOD CITY, Calif., Feb. 6, 2012 Cardica, Inc. (Nasdaq: ... fiscal second quarter ended December 31, 2011. Cardica,s management will ... to discuss the financial results and provide an update on ... progress on bringing our MicroCutter product line to the marketplace," ...
... 2012  A recent discovery by Van Andel Research Institute ... proposed drug therapies for glioblastoma – the most common ... The study, published in January in the ... , investigated glioblastoma models characterized by cell signaling activation ...
Cached Medicine Technology:Cardica Announces Fiscal 2012 Second Quarter Financial Results 2Cardica Announces Fiscal 2012 Second Quarter Financial Results 3Cardica Announces Fiscal 2012 Second Quarter Financial Results 4Cardica Announces Fiscal 2012 Second Quarter Financial Results 5Cardica Announces Fiscal 2012 Second Quarter Financial Results 6Discovery Predicts Patient Sensitivity to Important Drug Target in Deadly Brain Cancer 2
(Date:7/7/2015)... ... July 07, 2015 , ... Nationally-renowned attorneys ... their new website, the Invokana Ketoacidosis Lawsuit Center . The website provides ... a resource for persons wishing to learn more about Invokana lawsuits for kidney ...
(Date:7/7/2015)... ... July 07, 2015 , ... CSG Government ... been selected by the Department of Vermont Health Access to provide Quality Assurance ... System (MMIS) and Integrated Contact Center System project. , Vermont is implementing a ...
(Date:7/6/2015)... ... ... Respected southern California personal injury attorney Fernando D. Vargas has been honored ... has sharp legal skills as well as a superior commitment to client service. , ... a Top 10 Award from The National Academy of Personal Injury Attorneys (NAOPIA). , ...
(Date:7/6/2015)... ... July 06, 2015 , ... On June 22, 2015, Fox News in a report titled “ Female Hair Loss ... turn age 35 a quarter of all women in the U.S. will suffer from thinning ... stigmatized and rarely discussed. One woman, a former beauty queen, who was interviewed for the ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... The Asian-Pacific ... in 2014. It is expected to grow at a CAGR of over 3.2 percent ... , The growth is likely to be mainly spurred by an anticipated launch of ...
Breaking Medicine News(10 mins):Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 3Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2
... , WASHINGTON, Aug. 26 Danaher Corporation ... Executive Officer, H. Lawrence Culp, Jr. will be presenting at ... on Wednesday, September 2, 2009 at 12:30 p.m. EDT. The ... the webcast will be available for one week following the ...
... , MCLEAN, Va., Aug. 26 MicroStrategy((R)) ... provider of business intelligence (BI) software, today announced that ... has selected MicroStrategy to improve its sales reporting and ... international pharmaceuticals company Boehringer Ingelheim. , , ...
... , MISSION, Kan., Aug. 26 Like ... new ways to operate cost-effectively and use tax dollars wisely. ... administration program. And effective October 2009, Kansas City-based COBRAGuard, Inc. ... , Of course, with every outsourcing situation, ...
... ... anti-aging . , ... -- Every morning women all across America wake up, head to the makeup mirror, and add ... is hailed by Allure magazine as one of the most influential beauty breakthroughs of the decade, ...
... , , NEW YORK, Aug. 26 ... applied to the government broadband stimulus fund to provide broadband access ... areas exist in all 50 states because they are not connected ... or too disperse and challenging to dig ditches and lay wires. ...
... , SOUTHAMPTON, Pa., Aug. 26 ... the "Company") BioMedical Systems Division, a product division in ... SRL for the delivery and installation of the first ... , Histria International is a "turn-key" ...
Cached Medicine News:Health News:Boehringer Ingelheim's Swiss Branch Improves Sales Reporting and Efficiency with MicroStrategy Software 2Health News:Boehringer Ingelheim's Swiss Branch Improves Sales Reporting and Efficiency with MicroStrategy Software 3Health News:State of Kansas Streamlines COBRA Administration With Innovative Web-Based Solution 2Health News:5 Simple Ways to Take 10 Years Off Your Face 2Health News:5 Simple Ways to Take 10 Years Off Your Face 3Health News:5 Simple Ways to Take 10 Years Off Your Face 4Health News:01 Data Center Applied to Provide Broadband Access to Healthcare Facilities in Unserved Areas 2Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces First BARA-MED(R) Monoplace Hyperbaric Chamber Sale in Romania 2Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces First BARA-MED(R) Monoplace Hyperbaric Chamber Sale in Romania 3Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces First BARA-MED(R) Monoplace Hyperbaric Chamber Sale in Romania 4
... TOPLOAD 620/0.01G, BX620S. Digital stability control, ... measure, piece counting and percent measure ... including date and time data from ... external weights (selectable from 200g to ...
Guaranteed leak-proof , Teflon coating is impervious to corrosive materials , Shock-resistant , NBS tolerances of accuracy , Thermometers are 225 mm long with an immersion length of 35 mm ...
The EK-H Series offer 10 selectable units of measure...
Guaranteed leak-proof , Teflon coating is impervious to corrosive materials , Shock-resistant , NBS tolerances of accuracy , Thermometers are 225 mm long with an immersion length of 35 mm ...
Medicine Products: